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Background

Congenital scoliosis is a common type of vertebral malformation. Genetic susceptibility has been implicated in congenital scoliosis.
Methods

We evaluated 161 Han Chinese persons with sporadic congenital scoliosis, 166 Han
Chinese controls, and 2 pedigrees, family members of which had a 16p11.2 deletion, using comparative genomic hybridization, quantitative polymerase-chainreaction analysis, and DNA sequencing. We carried out tests of replication using an
additional series of 76 Han Chinese persons with congenital scoliosis and a multicenter series of 42 persons with 16p11.2 deletions.
Results

We identified a total of 17 heterozygous TBX6 null mutations in the 161 persons
with sporadic congenital scoliosis (11%); we did not observe any null mutations in
TBX6 in 166 controls (P<3.8×10−6). These null alleles include copy-number variants
(12 instances of a 16p11.2 deletion affecting TBX6) and single-nucleotide variants
(1 nonsense and 4 frame-shift mutations). However, the discordant intrafamilial
phenotypes of 16p11.2 deletion carriers suggest that heterozygous TBX6 null mutation is insufficient to cause congenital scoliosis. We went on to identify a common
TBX6 haplotype as the second risk allele in all 17 carriers of TBX6 null mutations
(P<1.1×10−6). Replication studies involving additional persons with congenital scoliosis who carried a deletion affecting TBX6 confirmed this compound inheritance
model. In vitro functional assays suggested that the risk haplotype is a hypomorphic allele. Hemivertebrae are characteristic of TBX6-associated congenital scoliosis.
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Conclusions

Compound inheritance of a rare null mutation and a hypomorphic allele of TBX6
accounted for up to 11% of congenital scoliosis cases in the series that we analyzed.
(Funded by the National Basic Research Program of China and others.)
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ongenital scoliosis, a form of vertebral malformation, has an estimated
prevalence of approximately 1 in 2000 live
births.1 It is manifested as a lateral curvature of
the spine exceeding 10 degrees and results from
defects in vertebra formation during embryogenesis.2,3
Previous evidence in animal models suggested
that genetic factors contribute to vertebral malformations.3,4 Genetic mutations have been implicated in human congenital scoliosis, but their
low penetrance highlights the complex molecular basis of the disorder and hinders molecular
diagnosis of and genetic counseling for congenital scoliosis.4,5
The proximal 16p11.2 deletion in humans is
rare but recurrent, with a population frequency of
approximately 0.03% worldwide.6 It is a likely
cause of common diseases, including autism and
obesity.7-9 Vertebral malformations have been observed in a small proportion of persons with
16p11.2 copy-number variants (including deletion
and duplication),10-12 a finding that suggests the
potential involvement of 16p11.2 copy-number
variants (specifically, deletions)13 in congenital
scoliosis.

Me thods
Study Participants

We enrolled 237 consecutive Han Chinese persons
who received a diagnosis of congenital scoliosis
between October 2010 and June 2014 at Peking
Union Medical College Hospital (PUMCH). Ancestry was determined by self-report (see the Methods
section in the Supplementary Appendix, available
with the full text of this article at NEJM.org). The
discovery set consisted of 161 persons with sporadic congenital scoliosis (series 1), and we tested
for replication in an additional series of 76 persons with the disorder (series 2). A clinical diagnosis of congenital scoliosis was confirmed by
radiologic imaging. We excluded persons with
syndromic diseases.
A total of 166 unrelated Han Chinese persons
with no evidence of congenital scoliosis or other
malformations served as population controls. We
also evaluated 2 Han Chinese pedigrees, family
members of which carried the 16p11.2 deletion
and had discordant intrafamilial phenotypes.
For a further replication study, 42 unrelated
persons with 16p11.2 deletion (series 3) were en342
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rolled from multiple centers in the United States
and China. These persons were initially referred for
clinical chromosomal microarray testing owing to
various medical problems.13-15
Cell Culture and Induced Differentiation

The P19CL6 cell line (derived from a mouse embryonic carcinoma) was cultured and differentiated into cardiomyocytes, as described previously.16 The cells were harvested every 24 hours after
treatment with dimethyl sulfoxide.17 We also used
a human induced pluripotent stem cell (hiPSC)
line that we derived from dermal fibroblasts by
means of an efficient and integration-free method.18 The culture of this hiPSC line and its induced differentiation to mesodermal-cell and
cardiac-cell lineages has been described previously.19,20 The cells were harvested 24 hours and
48 hours after differentiation with RPMI–B-27
medium without insulin.
Analysis of Genotype–Phenotype Correlation

We reviewed the medical records and spinal radiographs of all 237 persons with sporadic congenital scoliosis. Vertebral malformations were
classified as hemivertebra or hypoplasia, segmentation defect, or butterfly vertebra, as defined in a
previous report.21 Vertebral malformations at more
than one site in a patient were classified and counted independently according to location.
Study Oversight

This study was approved by the institutional review boards of the PUMCH, Fudan University, the
Capital Institute of Pediatrics, and the other participating institutions. We obtained written informed consent from the participants (those who
were ≥18 years of age at the time of enrollment)
or their guardians (for participants who were
<18 years of age).
Statistical Analysis

Fisher’s exact test was used to assess the difference in TBX6 mutation or variant frequencies between the persons with congenital scoliosis and
controls. The unpaired t-test was used for statistical analysis of the luciferase reporter assays. Pearson’s chi-square test was used to assess the difference in the prevalence of vertebral malformations
between persons with TBX6-associated congenital
scoliosis and those with congenital scoliosis but no
TBX6 nonsynonymous mutation. Odds ratios and
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95% confidence intervals were calculated. The
statistical analysis was performed with the use
of SPSS software, version 15.0 (SPSS). A two-sided
P value of less than 0.05 was considered to indicate statistical significance.
Further details of the study participants and of
assays using comparative genomic hybridization
(CGH), quantitative polymerase chain reaction,
DNA sequencing of TBX6, haplotyping of TBX6
variants, and luciferase assays can be found in
the Supplementary Appendix.

R e sult s
Prevalence of 16 p11.2 Deletions in Persons
with Congenital Scoliosis

A genomewide analysis of copy-number variants
was performed in 20 trios (consisting of a person
with sporadic congenital scoliosis and two healthy
parents) with the use of Agilent 1×1M CGH microarrays. We identified recurrent deletions in
proximal 16p11.2 (Fig. 1A) in two persons (Patient XH004 and Patient XH042) (Fig. S1 in the
Supplementary Appendix). Both of these heterozygous deletions were de novo (i.e., absent in the
patient’s parents).
Of the remaining 141 persons with sporadic
congenital scoliosis in series 1, 10 had a heterozygous 16p11.2 deletion (Table 1), whereas none
of the 166 Han Chinese controls had the deletion
(12 of 161 persons with congenital scoliosis vs.
0 of 166 controls, P<0.001 by Fisher’s exact test).
These findings are consistent with the rarity of
the 16p11.2 deletion in human populations
(0.03%).22,23 Remarkably, the prevalence of the
deletion among persons with sporadic congenital
scoliosis (12 of 161 persons, 7.5%) was much
higher than its reported prevalence among persons with autism (0.4 to 0.8%)6,7 or obesity
(0.7%),8,9 two phenotypes that it is known to
cause. None of our patients with congenital scoliosis were obese. Their detailed neurodevelopmental records were not available for us to evaluate symptoms of autism.
Association of TBX6 Loss-of-Function
Mutations with Congenital Scoliosis

The association of the 16p11.2 deletion with congenital scoliosis suggested that a gene related to
the disorder may be located in the segment of
DNA that is deleted: of these genes, TBX6 was
considered to be the best candidate (Fig. 1B).24-26
n engl j med 372;4

Accordingly, we hypothesized that other null or
loss-of-function mutations (e.g., nonsense, frameshift, and essential splice-site variants)27 of TBX6
cause congenital scoliosis. One heterozygous nonsense and four heterozygous frame-shift mutations of TBX6 were identified among the patients
with congenital scoliosis in series 1 (Table 1, and
Fig. S2 in the Supplementary Appendix). The frameshift mutation in Patient XH122 was de novo,
whereas the status (i.e., de novo or inherited) of the
other four null mutations is unknown. In contrast, we did not observe any null mutations in the
controls (5 of 161 persons with congenital scoliosis vs. 0 of 166 controls, P = 0.03 by Fisher’s exact
test). These findings suggest an association of
TBX6 null mutations with congenital scoliosis.
Furthermore, we identified TBX6 missense
mutations in 7 of 161 persons with congenital
scoliosis in series 1, a prevalence higher than
that among the controls (3 of 166 persons) and
among Han Chinese populations in Beijing and
in southern China (CHB and CHS populations)
in the 1000 Genomes Project (1 of 197 persons)
(Fig. S3 and Tables S1 through S4 in the Supplementary Appendix).22 In a combined analysis,
the association of TBX6 missense mutations with
congenital scoliosis was significant (7 of 161 persons with congenital scoliosis vs. 4 of 363 controls, P = 0.04 by Fisher’s exact test). Because missense mutations could be benign or even confer a
gain of function, we did not include them in additional analyses, although we cannot exclude the
possibility of a role for them in congenital scoliosis.
A Common Risk Haplotype in Null Mutation
Carriers

Each person with congenital scoliosis in series 1
who carried a TBX6 mutation was found to have
only one null mutation (Table 1), which, at face
value, suggests a simple dominant mode of inheritance. However, dominant inheritance is not
supported by the low penetrance of congenital
scoliosis in carriers of the 16p11.2 deletion affecting TBX6.10-12 We therefore hypothesized that
an additional genetic modifier acts in concert with
TBX6 null mutations to cause congenital scoliosis.
To test this hypothesis, we analyzed two
pedigrees with an affected member and unaffected members who had the same 16p11.2 deletion. In Pedigree SE1 (Fig. 1C), the proband had
congenital scoliosis with hemivertebra, whereas
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A Genomic Region Affected by Proximal 16p11.2 Deletion
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Figure 1. Effect of the 16p11.2 Deletion on TBX6.
Panel A shows the region affected by the proximal 16p11.2 deletion based on the human genome assembly hg19. A
pair of long direct genomic repeats (shown in orange) can mediate 0.6-Mb recurrent deletions. The genes affected by
this deletion, including TBX6 (circled), are shown. Panel B shows three common single-nucleotide polymorphisms
(SNPs) in TBX6. Two SNPs, rs3809624 and rs3809627, are located in the 5′ noncoding region, whereas rs2289292
is a synonymous SNP in the last exon. Panels C and D show two pedigrees with 16p11.2 deletions (SE1 and SE2).
Squares denote male pedigree members, circles female pedigree members, solid symbols members with congenital
scoliosis, and open symbols unaffected members; the probands are indicated by black arrows. The red bracket represents the deletion allele, and the nonreference alleles of rs2289292, rs3809624, and rs3809627 on the nondeletion
chromosomes are shown in blue. The slash denotes a deceased family member. NA denotes not available.

the father and sibling had the same deletion but
did not have congenital scoliosis.12 In Pedigree SE2
(Fig. 1D), the deletion in the proband was paternally inherited. The radiograph revealed a wedgeshaped vertebral malformation in the proband
(Fig. 2); congenital scoliosis was not observed in
the father.
We did not identify a rare mutation in TBX6,

344
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other than the deletion itself, in any of the family members. However, we did observe a common
TBX6 haplotype of T-C-A (defined by the nonreference alleles of three common single-nucleotide
polymorphisms [SNPs] — rs2289292, rs3809624,
and rs3809627, respectively) that cosegregated
with congenital scoliosis in both pedigrees
(Fig. 1). Therefore, we further evaluated the 17
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Table 1. Genetic and Clinical Characteristics of Patients with TBX6-Associated Congenital Scoliosis.
Patient No.

Sex

TBX6 Allele

Age (yr)

Null Mutation
at First Allele

Vertebral Malformation*

Other Congenital Malformation

Risk Haplotype
at Second
Allele†

Congenital scoliosis series 1 (discovery)
XH004

F

4

16p11.2 del

T-C-A

L1 hemivertebra (left)

XH025

M

3

16p11.2 del

T-C-A

T11 hemivertebra (left)

Rib abnormality (missing left 11th rib)

None

XH042

M

6

16p11.2 del

T-C-A

T9 hemivertebra (left)

Patent foramen ovale and rib abnormalities
(missing right 9th and left 12th ribs)

XH141

F

18

16p11.2 del

T-C-A

T4 hemivertebra (left)

Syringomyelia, spina bifida, and rib abnormalities (fused left 3rd through 6th ribs)

XH149

F

7

16p11.2 del

T-C-A

T12 hemivertebra (right)

Rib abnormality (missing left 12th rib)

XH186

M

4

16p11.2 del

T-C-A

T11 hemivertebra (left)

Rib abnormality (missing right 11th rib)

XH237

M

13

16p11.2 del

T-C-A

T12 hemivertebra (left) and L3 Rib abnormality (missing right 12th rib)
butterfly vertebra

XH265

M

4

16p11.2 del

T-C-A

L1 hemivertebra (right)

XH270

M

14

16p11.2 del

T-C-A

T11 and T12 hemivertebrae
(left)

XH292

F

11

16p11.2 del

T-C-A

T6 hemivertebra (left) and T12 Rib abnormality (missing right 6th rib)
wedge vertebra

XH300

M

3

16p11.2 del

T-C-A

T10 hemivertebra (left)

Rib abnormalities (missing right 10th rib
and bifurcation of right 9th rib)

XH303

M

5

16p11.2 del

T-C-A

T7 butterfly vertebra and T12
hemivertebra (left)

Rib abnormality (missing left 12th rib)

XH101

F

7

c.1250_1251insT
frame shift

T-C-A

L2 hemivertebra (left)

Atrial septal defect and rib abnormalities
(missing bilateral 12th ribs)

XH122

M

5

c.266_267insC
frame shift

T-C-A

Hemivertebra (left) between
T12 and L1

Rib abnormality (missing right 12th rib)

XH170

M

5

c.704_705insG
frame shift

T-C-A

T12 hemivertebra (left)

Rib abnormality (missing right 12th rib)

XH286

M

2

c.1169_1170insC
frame shift

T-C-A

L2 hemivertebra (left) and T8
butterfly vertebra

None

XH148

F

16

c.844C→T
(p.R282X)

T-C-A

T1 and L3 butterfly vertebrae,
T4 hemivertebra (right),
and T7 hemivertebra (left)

None

T-C-A

Hemivertebra (left) between
T12 and L1

None

None
Rib abnormalities (missing right 12th rib
and bifurcation of right 2nd rib)

Congenital scoliosis series 2 (replication)
XR345

F

13

16p11.2 del

XR353

M

11

16p11.2 del

T-C-A

T11 hemivertebra (right)

Rib abnormality (missing left 11th rib)

XR402

M

11

16p11.2 del

T-C-A

C5 hemivertebra (left), T5
hemivertebra (right), and
T8 hemivertebra (left)

Rib abnormalities (missing left 5th and
right 8th ribs)

XR434

F

16

16p11.2 del

T-C-A

T12 hemivertebra (left) and T9
butterfly vertebra

XR439

F

7

16p11.2 del

T-C-A

L3 hemivertebra (right)

XR341

M

2

c.1179_1180delAG
frame shift

T-C-A

T12 hemivertebra (right)

None
None
Rib abnormality (missing left 12th rib)

* C denotes cervical, L lumbar, and T thoracic.
† T-C-A represents the haplotype defined by three common TBX6 single-nucleotide polymorphisms (reference/nonreference): rs2289292
(C/T), rs3809624 (T/C), and rs3809627 (C/A).
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Figure 2. Spinal Radiographs in Patients with TBX6-Associated Congenital Scoliosis.
The vertebrae with malformations are indicated by arrows. The patient number is shown above each radiograph.

T-C-A risk haplotype at the second allele in all
persons with these mutations. The TBX6 compound inheritance model accounts for 6 of 76 cases
of congenital scoliosis (8%) in series 2 (Table 2).
Furthermore, we enrolled 42 persons with the
16p11.2 deletion (series 3) from multiple centers
(Table S6 in the Supplementary Appendix). These
persons were categorized into three subgroups:
those with congenital scoliosis (vertebral malformations), those who had scoliosis without vertebral malformations, and those with no evidence
of scoliosis. This made it feasible to investigate
whether the hemizygous T-C-A haplotype is associated with congenital scoliosis in 16p11.2 deletion carriers. In the congenital scoliosis subgroup,
we identified 5 of 6 persons (83%) as having the
Replication Studies
hemizygous T-C-A haplotype (Table 2). The only
We recruited an additional 76 persons with con- exception (Patient PT03) was of African ancestry,13
genital scoliosis (series 2) and identified 6 TBX6 and the T-C-A haplotype is rare among such pernull mutations (Table 1). Again, we observed the sons (prevalence, <1% among Africans, as compersons with congenital scoliosis in series 1 who
had the TBX6 null mutations. All 17 persons carried the T-C-A haplotype at the second TBX6 allele (Table 1). The probability of this coinheritance is P = (44%)17, which is equivalent to
P<1.1×10−6, where 44% is the frequency of the
T-C-A haplotype among Han Chinese persons in
the 1000 Genomes Project (Table S5 in the Supplementary Appendix).22 Our observations suggest a genetic model of TBX6 compound inheritance involving a combination of rare null and
common risk alleles in the causation of congenital scoliosis. This model accounts for 17 of 161
cases of congenital scoliosis (11%) in series 1
(Table 2).
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Table 2. Distribution of Cases of TBX6-Associated Congenital Scoliosis.
No. of
Patients

Series

Cases of Congenital Scoliosis Explained
by TBX6 Compound Inheritance

P Value

percent
Series 1: patients with congenital scoliosis

161

11

<3.8×10−6*

Series 2: patients with congenital scoliosis

76

8

<8.4×10−4†

Series 3: patients with 16p11.2 deletion

42‡

83

0.004§

* The P value was calculated on the basis of 17 of 161 patients with congenital scoliosis versus 0 of 166 controls.
† The P value was calculated on the basis of 6 of 76 patients with congenital scoliosis versus 0 of 166 controls.
‡ Six of 42 patients with 16p11.2 deletion had a congenital scoliosis phenotype.
§ The P value was calculated on the basis of 5 of 6 deletion carriers with congenital scoliosis versus 5 of 30 deletion carriers
without scoliosis.

pared with 44% among Asians and 33% among
persons of European descent) (Table S5 in the
Supplementary Appendix). Patient PT03 had the
nonreference allele of SNP rs111939223 (present
in 4% of Yoruba Africans but absent in Asians
and Europeans), which is located at a predicted
messenger RNA polyadenylation site of TBX6.28
Therefore, we cannot exclude the possibility of
compound inheritance of a TBX6 null mutation
and an alternative risk haplotype among persons
of African ancestry in Patient PT03.
In the no-scoliosis subgroup, the T-C-A haplotype was present in only 5 of 30 persons (17%)
(Table S7 in the Supplementary Appendix). The
T-C-A risk haplotype was a significant risk factor
for congenital scoliosis in series 3 (5 of 6 persons
with congenital scoliosis vs. 5 of 30 persons without scoliosis, P = 0.004 by Fisher’s exact test), which
further supports the TBX6 compound inheritance
model of the disorder.
The Hypomorphic Risk Haplotype In Vitro

The TBX6 SNPs defining the haplotype for risk of
congenital scoliosis could be functional or, alternatively, could be a composite genetic marker
that is linked with the true functional variants.
We conducted a linkage-disequilibrium analysis
using common human SNPs22 and found that
the linkage-disequilibrium block of TBX6 is short
(5 kb by the four-gamete rule) (Fig. S4 in the
Supplementary Appendix). We identified no rare
mutation in this block. The most parsimonious
explanation for this observation is that the common TBX6 SNPs defining the risk haplotype are
functional.
The SNPs rs3809624 and rs3809627 are located in the 5′ noncoding region of TBX6 (Fig.
1B), potentially regulating TBX6 expression.29
n engl j med 372;4

Data from the Encyclopedia of DNA Elements
(ENCODE) Project suggest the possible involvement of these two noncoding SNPs in the regulation of gene expression.30 For example, both
SNPs are located in the same binding site of upstream stimulatory factor 1 (USF1), a transcription
factor potentially involved in somitogenesis.31,32
We used in vitro luciferase assays to study the
effects of rs3809624 and rs3809627 on gene expression. Preliminary analyses in three human cell
lines (HEK293, HepG2, and HeLa) showed significant reductions in the expression of the reporter
gene when linked to the portion of TBX6 harboring
nonreference variants at both rs3809624 and
rs3809627 (Fig. S5 and S6 in the Supplementary
Appendix). We carried out the same experiment
using the multipotent P19CL6 cells16,17 and
hiPSCs. TBX6 was strongly expressed in these
stem cells when they differentiated into mesodermal-cell lineages (Fig. S5 in the Supplementary Appendix). We observed that P19CL6 cells
and hiPSCs carrying the luciferase reporter construct with nonreference alleles at both rs3809624
and rs3809627 expressed significantly less reporter protein on differentiation into mesodermal and cardiac cells (Fig. 3A). These findings
consistently support the hypomorphic effects
of the combination of nonreference alleles at
rs3809624 and rs3809627 on TBX6 expression.
Hemivertebrae in Persons with TBX6Associated Congenital Scoliosis

To assess the influence of TBX6 disruption on the
morphologic features of vertebral malformations,
we evaluated the types of vertebral malformations
in 23 persons with sporadic congenital scoliosis
and TBX6 null mutations and in 204 persons with
sporadic congenital scoliosis and no detected TBX6
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Figure 3. Results of In Vitro Functional Assays of Common TBX6 Variants
and the Mechanistic Model of TBX6-Associated Congenital Scoliosis.
Panel A shows the results of luciferase reporter assays. Two cell types
(P19CL6 cells and human induced pluripotent stem cells [hiPSCs]) with
high levels of expression of TBX6 during induced differentiation were used.
The nonreference alleles of rs3809624 and rs3809627 are shown in blue,
and the risk haplotype is underlined. At least three independent experiments
of normalized luciferase activity were quantified, with the graph showing
mean values and their standard errors (I bars). Panel B shows a simplified
genetic model of TBX6-associated congenital scoliosis. TBX6 expression is
critical for normal vertebral formation (the reference allele of TBX6 is indicated by a black line). Heterozygous hypomorphic variants (shown in blue)
cause only a moderate reduction in TBX6 expression. Even homozygous
hypomorphic variants do not reduce TBX6 expression dramatically. Heterozygous TBX6 null mutations (indicated by red brackets) may reduce gene
expression by one half. Independently, these mutations hardly reach the
gene-dosage threshold for congenital scoliosis. In combination, however,
a null allele and a hypomorphic allele of TBX6 cause further reductions in
gene expression that may confer a high risk of congenital scoliosis.

nonsynonymous mutations. All 23 persons with
TBX6-associated congenital scoliosis had one or
more hemivertebrae (Table 1 and Fig. 2). The
number of hemivertebrae was significantly higher in the persons with TBX6-associated congeni348
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tal scoliosis than in those with congenital scoliosis but no apparent TBX6 mutation (P<0.001)
(Table S8 in the Supplementary Appendix).
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The genetic basis for the risk of congenital scoliosis is poorly understood. The involvement of
Tbx6 in vertebral malformations in mice has been
suggested.4,25,33 However, a previous study involving 50 persons with congenital vertebral malformations identified no TBX6 mutations,5 and only a
weak association between common TBX6 SNPs
and congenital scoliosis in the Han Chinese population was reported previously.26 Our data show
that TBX6 null mutations are associated with sporadic congenital scoliosis, and in conjunction with
the TBX6 haplotype of T-C-A, these mutations accounted for 8 to 11% of congenital scoliosis cases in the study population with the disorder
(Table 2). TBX6 null mutations and noncoding
variants therefore contribute substantively to the
complex trait of sporadic congenital scoliosis.
Generally, the molecular mechanism of human
mendelian disorders associated with heterozygous gene deletions or null mutations is haploinsufficiency, in which half the gene dosage is
not sufficient for normal function.34,35 In contrast, the effect of diminished TBX6 dosage in
congenital scoliosis is complex. We found that
an additional TBX6 hypomorphic allele is required
to cause a further decrement in gene-expression
dosage beyond haploinsufficiency for penetrance
of the congenital scoliosis phenotype (Fig. 3B).
A precedent for the mechanism of compound
inheritance was provided by a recent study of human thrombocytopenia with absent radii (TAR)
associated with the gene RBM8A in 1q21.1.36 The
compound inheritance of TBX6 in congenital scoliosis, like that of RBM8A in TAR and analogous
to a recessive trait, requires two mutant alleles at
a genetic locus for trait manifestation. This model
may also pertain to phenotypic variation and penetrance of particular endophenotypes manifested
in other genomic disorders that are associated
with large-scale copy-number variants.37-39
The phenotypes of sporadic congenital scoliosis can be dramatically different. However, the
23 persons whom we found to have TBX6-associated congenital scoliosis were phenotypically
consistent with one another, having one or more
hemivertebrae. A heterozygous TBX6 stop-loss mutation (p.*437Cext*81) was reported in a pedigree
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with dominantly inherited spondylocostal dysostosis, a specific group of vertebral abnormalities
characterized by multiple segmentation defects
of the vertebrae, malalignment of the ribs (though
often with a symmetric thoracic cage), and nonprogressive scoliosis.40,41 Functional studies
showed that this mutation caused partial reduction in the ability of TBX6 to activate transcription.41 We further analyzed this previously
reported pedigree and found that this TBX6
stop-loss mutation was located within the T-C-A
risk haplotype. The combined reduction in
TBX6 expression and transcriptional activation
might therefore account for spondylocostal dysostosis in this family. Alternatively, the 81 amino acids added to the C-terminal may affect the
ability of TBX6 to interact with other proteins
that are critical in vertebral formation, such as
MESP2 and RIPPLY2.42,43
Environmental factors could also contribute
to the variety of phenotypes of TBX6-associated
congenital scoliosis. Mouse embryos are susceptible to gestational hypoxia, and developmental
processes such as somitogenesis are affected by
cellular hypoxia.4,44 Moreover, gene–environment
interactions can affect the penetrance of vertebral
phenotypes in mouse embryos that are geneti-

cally predisposed to vertebral defects. Similar
mechanisms could affect the phenotypes of
persons with variants in and deletions of TBX6.4
Our data suggest that TBX6 mutations are a
common genetic cause of congenital scoliosis in
the populations from which we drew our samples. Our finding that compound inheritance of
a rare TBX6 null mutation and a common risk
haplotype causes congenital scoliosis will enable
the molecular diagnosis of the disorder and genetic counseling for some persons who have or
are at risk for congenital scoliosis.
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